CNSP — CNS Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for CNS Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	5	10.1	0.549	6.46	7.2
Net Total Receivables	—	—	—	0.883	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	7.48	12.6	1.59	8.66	8.1
Net Property, Plant And Equipment	0.016	0.006	0.005	0.006	0.018
Other Long Term Assets
Total Assets	8.76	13.1	1.7	8.7	8.62
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	2.59	4.92	6.13	2.52	4.1
Total Long Term Debt
Total Debt
Total Liabilities	2.59	4.92	6.13	2.52	4.1
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	6.16	8.13	-4.43	6.18	4.52
Total Liabilities & Shareholders' Equity	8.76	13.1	1.7	8.7	8.62
Total Common Shares Outstanding